These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33826022)

  • 61. Low costs and opportunities for efficiency: a cost analysis of the first year of programmatic PrEP delivery in Kenya's public sector.
    Peebles K; Mugwanya KK; Irungu E; Odoyo J; Wamoni E; Morton JF; Ngure K; Bukusi EA; Mugo NR; Masyuko S; Mukui I; Baeten JM; Barnabas RV;
    BMC Health Serv Res; 2021 Aug; 21(1):823. PubMed ID: 34399736
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Uptake of a patient-centred dynamic choice model for HIV prevention in rural Kenya and Uganda: SEARCH SAPPHIRE study.
    Kabami J; Kakande E; Chamie G; Balzer LB; Petersen ML; Camlin CS; Nyabuti M; Koss CA; Bukusi EA; Kamya MR; Havlir DV; Ayieko J
    J Int AIDS Soc; 2023 Jul; 26 Suppl 1(Suppl 1):e26121. PubMed ID: 37408473
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: results from an implementation programme.
    Kinuthia J; Pintye J; Abuna F; Mugwanya KK; Lagat H; Onyango D; Begnel E; Dettinger J; Baeten JM; John-Stewart G;
    Lancet HIV; 2020 Jan; 7(1):e38-e48. PubMed ID: 31813837
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cost of pre-exposure prophylaxis delivery in family planning clinics to prevent HIV acquisition among adolescent girls and young women in Kisumu, Kenya.
    Wanga V; Peebles K; Obiero A; Mogaka F; Omollo V; Odoyo JB; Morton JF; Bukusi EA; Celum C; Baeten JM; Barnabas RV
    PLoS One; 2021; 16(4):e0249625. PubMed ID: 33857195
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.
    Baeten JM; Heffron R; Kidoguchi L; Mugo NR; Katabira E; Bukusi EA; Asiimwe S; Haberer JE; Morton J; Ngure K; Bulya N; Odoyo J; Tindimwebwa E; Hendrix C; Marzinke MA; Ware NC; Wyatt MA; Morrison S; Haugen H; Mujugira A; Donnell D; Celum C;
    PLoS Med; 2016 Aug; 13(8):e1002099. PubMed ID: 27552090
    [TBL] [Abstract][Full Text] [Related]  

  • 66. PrEP Implementation for Mothers in Antenatal Care (PrIMA): study protocol of a cluster randomised trial.
    Dettinger JC; Kinuthia J; Pintye J; Mwongeli N; Gómez L; Richardson BA; Barnabas R; Wagner AD; O'Malley G; Baeten JM; John-Stewart G
    BMJ Open; 2019 Mar; 9(3):e025122. PubMed ID: 30850409
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Provider Perspectives on HIV Pre-Exposure Prophylaxis Service Disruptions and Adaptations During the COVID-19 Pandemic in Baltimore, Maryland: A Qualitative Study.
    Rosen JG; Zhang L; Pelaez D; Coleman JS; To C; Cooper L; Olatunde PF; Toomre T; Glick JL; Park JN
    AIDS Patient Care STDS; 2022 Aug; 36(8):313-320. PubMed ID: 35951445
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Perspectives on the utility and interest in a point-of-care urine tenofovir test for adherence to HIV pre-exposure prophylaxis and antiretroviral therapy: an exploratory qualitative assessment among U.S. clients and providers.
    Bardon AR; Simoni JM; Layman LM; Stekler JD; Drain PK
    AIDS Res Ther; 2020 Aug; 17(1):50. PubMed ID: 32762713
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Acceptability of HIV Pre-Exposure Prophylaxis (PrEP) and Implementation Challenges Among Men Who Have Sex with Men in India: A Qualitative Investigation.
    Chakrapani V; Newman PA; Shunmugam M; Mengle S; Varghese J; Nelson R; Bharat S
    AIDS Patient Care STDS; 2015 Oct; 29(10):569-77. PubMed ID: 26348459
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Putting PrEP into Practice: Lessons Learned from Early-Adopting U.S. Providers' Firsthand Experiences Providing HIV Pre-Exposure Prophylaxis and Associated Care.
    Calabrese SK; Magnus M; Mayer KH; Krakower DS; Eldahan AI; Gaston Hawkins LA; Hansen NB; Kershaw TS; Underhill K; Betancourt JR; Dovidio JF
    PLoS One; 2016; 11(6):e0157324. PubMed ID: 27304883
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Determinants of Implementation for HIV Pre-exposure Prophylaxis Based on an Updated Consolidated Framework for Implementation Research: A Systematic Review.
    Li DH; Benbow N; Keiser B; Mongrella M; Ortiz K; Villamar J; Gallo C; Deskins JS; Xavier Hall CD; Miller C; Mustanski B; Smith JD
    J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S235-S246. PubMed ID: 35703776
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Women's preferences for HIV prevention service delivery in pharmacies during pregnancy in Western Kenya: a discrete choice experiment.
    Mugambi ML; Odhiambo BO; Dollah A; Marwa MM; Nyakina J; Kinuthia J; Baeten JM; Weiner BJ; John-Stewart G; Barnabas RV; Hauber B
    J Int AIDS Soc; 2024 Jul; 27 Suppl 1(Suppl 1):e26301. PubMed ID: 38965978
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Estimating the costs and perceived benefits of oral pre-exposure prophylaxis (PrEP) delivery in ten counties of Kenya: a costing and a contingent valuation study.
    Forsythe S; Kioko U; Mahiane G; Glaubius R; Musau A; Gichangi A; Reed J; Were D
    Front Reprod Health; 2024; 6():1278764. PubMed ID: 38463424
    [TBL] [Abstract][Full Text] [Related]  

  • 74. HIV PrEP is more than ART-lite: Longitudinal study of real-world PrEP services data identifies missing measures meaningful to HIV prevention programming.
    Reed JB; Shrestha P; Were D; Chakare T; Mutegi J; Wakhutu B; Musau A; Nonyana NM; Christensen A; Patel R; Rodrigues J; Eakle R; Curran K; Mohan D
    J Int AIDS Soc; 2021 Oct; 24(10):e25827. PubMed ID: 34648678
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pre-exposure prophylaxis awareness, acceptability and potential stigma among medical and non-medical clinic staff in methadone treatment settings in northern New Jersey: The key role of non-medical staff in enhancing HIV prevention.
    Jaiswal J; Dunlap K; Griffin M; Cox A; Singer SN; Hascher K; LoSchiavo C; Walters SM; Mumba M
    J Subst Abuse Treat; 2021 Oct; 129():108371. PubMed ID: 34080542
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Barriers and facilitators to pre-exposure prophylaxis (PrEP) eligibility screening and ongoing HIV testing among target populations in Bondo and Rarieda, Kenya: results of a consultation with community stakeholders.
    Mack N; Odhiambo J; Wong CM; Agot K
    BMC Health Serv Res; 2014 May; 14():231. PubMed ID: 24886646
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Structural, Dosing, and Risk Change Factors Affecting Discontinuation of Pre-exposure Prophylaxis (PrEP) in a Large Urban Clinic.
    Shover CL; DeVost MA; Cunningham NJ; Beymer MR; Flores D; Flynn R; Gorbach PM; Lyman P; Amico KR; Bolan RK
    AIDS Educ Prev; 2020 Aug; 32(4):271-S13. PubMed ID: 32897133
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High Awareness, Yet Low Uptake, of Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women Within Family Planning Clinics in Kenya.
    Sila J; Larsen AM; Kinuthia J; Owiti G; Abuna F; Kohler PK; John-Stewart G; Pintye J
    AIDS Patient Care STDS; 2020 Aug; 34(8):336-343. PubMed ID: 32757980
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.
    Pleuhs B; Quinn KG; Walsh JL; Petroll AE; John SA
    AIDS Patient Care STDS; 2020 Mar; 34(3):111-123. PubMed ID: 32109141
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.
    Koss CA; Havlir DV; Ayieko J; Kwarisiima D; Kabami J; Chamie G; Atukunda M; Mwinike Y; Mwangwa F; Owaraganise A; Peng J; Olilo W; Snyman K; Awuonda B; Clark TD; Black D; Nugent J; Brown LB; Marquez C; Okochi H; Zhang K; Camlin CS; Jain V; Gandhi M; Cohen CR; Bukusi EA; Charlebois ED; Petersen ML; Kamya MR; Balzer LB
    PLoS Med; 2021 Feb; 18(2):e1003492. PubMed ID: 33561143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.